NATICK, Mass.--(BUSINESS WIRE)--
Cognex
Corporation (NASDAQ: CGNX) today announced financial results for the
first quarter of 2018. Table 1 below shows selected financial data for
Q1-18 compared with Q1-17 and Q4-17. All periods presented reflect the
two-for-one stock split in Q4-17.
|
Table 1*
(Dollars in thousands, except per share amounts)
|
|
|
|
|
Revenue
|
|
|
Net Income/(loss)
|
|
|
Net Income/(loss) per Diluted Share
|
|
|
Non-GAAP Net Income/(loss) per Diluted Share**
|
|
Quarterly Comparisons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current quarter: Q1-18
|
|
|
$169,567
|
|
|
$37,217
|
|
|
$0.21
|
|
|
$0.18
|
|
Prior year's quarter: Q1-17
|
|
|
$139,039 |
|
|
$45,471 |
|
|
$0.25 |
|
|
$0.18 |
|
Change: Q1-17 to Q1-18
|
|
|
22%
|
|
|
(18%)
|
|
|
(16%)
|
|
|
0%
|
|
Prior quarter: Q4-17
|
|
|
$182,922 |
|
|
($27,747)
|
|
|
($0.16)
|
|
|
$0.24 |
|
Change: Q4-17 to Q1-18
|
|
|
(7%)
|
|
|
N/M
|
|
|
N/M
|
|
|
(25%)
|
* The financial results for all periods presented reflect the
retroactive adoption of a new revenue recognition standard (ASC 606,
"Revenue from Contracts with Customers") that became effective on
January 1, 2018. This standard did not have a material impact on total
revenue. For a historical perspective, Exhibit 4 of this news release
includes the company's quarterly Statement of Operations for 2017
adjusted for the impact of the new standard.
**Non-GAAP net income/(loss) per diluted share excludes tax adjustments.
A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this
news release.
"Overall, our results for Q1 2018 were good," said Dr.
Robert J. Shillman, Founder and Chairman of Cognex. "Revenue grew
22% year-on-year, which was above our long-term target for revenue
growth. We were also highly profitable, reporting an operating margin of
20% and a net margin of 22%. Nevertheless, while many companies would
applaud these results, we are dissatisfied given the higher levels of
profitability that we demonstrated in 2017."
"Revenue in Q1 grew across most end markets and geographic regions,
reflecting broad demand for our products," said Robert
J. Willett, Chief Executive Officer of Cognex. "Investing for the
future remains key to our ongoing success, and, therefore, we will
continue to aggressively develop new products, expand our world-wide
sales force and make strategic IT and infrastructure investments."
Mr. Willett continued, "Following a record year in 2017, we face tough
comparisons this year, particularly in the second half, due to
anticipated lower demand from consumer electronics—our largest industry
vertical. Because of that, we believe that Cognex revenue over the next
nine months will be relatively flat in total with the comparable period
in 2017."
Details of the Quarter
Statement of Operations Highlights - First Quarter of 2018
-
Revenue increased 22% from Q1-17 and declined 7% from Q4-17. In
constant currency, revenue grew 17% year-on-year and declined 9%
sequentially. Revenue from the majority of the company's end markets
grew worldwide, both year-on-year and sequentially. A notable
exception was revenue from the consumer electronics industry, which
declined from both Q1-17 and Q4-17.
-
Gross margin was 76% for Q1-18 compared with 77% for Q1-17 and 76% for
Q4-17. Gross margin decreased year-on-year due primarily to a slight
increase in the proportion of service-related revenue.
-
Research, Development & Engineering (RD&E) expenses increased 36% from
Q1-17 and 15% from Q4-17. The increases in RD&E reflect higher
sequential and year-on-year investments in engineering resources and
employee-related costs for the development of new products, as well as
a sequential increase in support of high-volume opportunities.
-
Selling, General & Administrative (SG&A) expenses increased 37% from
Q1-17 and 5% from Q4-17. SG&A increased year-on-year and sequentially
due to investments in sales resources and higher employee-related
costs.
-
Cognex reported foreign currency losses of $134,000 in Q1-18, $263,000
in Q1-17, and $1,027,000 in Q4-17. The foreign currency losses result
primarily from the revaluation and settlement of accounts receivable
balances reported in one currency and collected in another.
-
Investment and other income was $3,517,000 in Q1-18, $2,282,000 in
Q1-17, and $2,923,000 in Q4-17. Investment income increased both
year-on-year and sequentially due primarily to higher yields on
invested balances.
-
The effective tax rate was 2% in Q1-18, (16%) in Q1-17, and 153% in
Q4-17. The rate was 15%, 18% and 18%, respectively, excluding tax
adjustments (which are summarized in Exhibit 2). Notably, the Tax Cuts
and Jobs Act resulted in a net tax charge of $83 million in Q4-17. All
periods presented include a varying discrete tax benefit related to
employee stock options exercised during that quarter.
Balance Sheet Highlights - April 1, 2018
-
Cognex's financial position as of April 1, 2018, continued to be very
strong, with $803 million in cash and investments and no debt. Cash
and investments decreased by $25 million from the end of 2017. During
the quarter, cash inflows consisted of $55 million generated from
operations and $11 million received from the exercise of employee
stock options. Cash outflows included $69 million spent to repurchase
Cognex common stock, $8 million in dividends paid to shareholders, and
$13 million for capital expenditures. Cognex intends to continue to
repurchase shares of its common stock in Q2-18, subject to market
conditions and other relevant factors.
-
Inventories increased by $28 million, or 42%, from the end of 2017, to
prepare for large customer shipments expected in the coming quarters
and to meet upcoming new product introductions.
Financial Outlook - Q2 2018
This financial outlook reflects the new revenue recognition standard
(ASC 606, "Revenue from Contracts with Customers") that took effect on
January 1, 2018. Cognex does not believe this standard will have a
material impact on total revenue. For a historical perspective, Exhibit
4 of this news release includes the company's quarterly Statement of
Operations for 2017 adjusted for the impact of the new standard.
-
Revenue for Q2-18 is expected to be between $200 million and $210
million, which represents growth between 12% and 18% year-on-year.
-
Gross margin is expected to be in the mid-70% range, which is Cognex's
target range for gross margin under the new revenue recognition
standard.
-
Operating expenses are expected to be essentially flat on a sequential
basis.
-
The effective tax rate is expected to be 15% before discrete tax items.
Non-GAAP Financial Measures
-
Exhibit 2 of this news release includes a reconciliation of certain
financial measures from GAAP to non-GAAP. Cognex believes these
non-GAAP financial measures are helpful because they allow investors
to more accurately compare Cognex results over multiple periods using
the same methodology that management employs in its budgeting process
and in its review of Cognex's operating results. Non-GAAP
presentations exclude the following: (1) stock option expense for
calculating non-GAAP adjusted operating income and net income from
continuing operations (because these expenses have no current effect
on cash or the future uses of cash, and they fluctuate because of
changes in Cognex's stock price), and (2) certain one-time discrete
events, such as tax adjustments (because these costs are outside of
Cognex's normal business operations). Cognex also uses results on a
constant-currency basis as one measure to evaluate performance.
Constant-currency information compares results between periods as if
the exchange rates had remained constant period-over-period. Cognex
does not intend for non-GAAP financial measures to be considered in
isolation, or as a substitute for financial information provided in
accordance with GAAP.
-
The tax effect of items identified in the reconciliation is estimated
by applying the effective tax rate to the pre-tax amount. However, if
a specific tax rate or tax treatment is required because of the nature
of the item and/or the tax jurisdiction where the item was recorded,
the tax effect is estimated by applying the relevant specific tax rate
or tax treatment, rather than the effective tax rate.
Analyst Conference Call and Simultaneous Webcast
-
Cognex will host a conference call today at 5:00 p.m. Eastern Time
(ET). The telephone number is (877) 704-4573 (or (201) 389-0911 if
outside the United States). A replay will begin at 8:00 p.m. ET today
and will be available until 11:59 p.m. ET on Thursday, May 3, 2018.
The telephone number for the replay is (877) 660-6853 (or (201)
612-7415 if outside the United States). The access code for both the
live call and the replay is 13677872.
-
Internet users can listen to a real-time audio broadcast of the
conference call or an archived recording on the Cognex Investor
Relations website: http://www.cognex.com/Investor.
About Cognex Corporation
Cognex Corporation designs, develops, manufactures and markets a wide
range of image-based products, all of which use artificial intelligence
(AI) techniques that give them the human-like ability to make decisions
on what they see. Cognex products include machine vision systems,
machine vision sensors and barcode readers that are used in factories
and distribution centers around the world where they eliminate
production and shipping errors.
Cognex is the world's leader in the machine vision industry, having
shipped more than 1.5 million vision-based products, representing over
$5 billion in cumulative revenue, since the company's founding in 1981.
Headquartered in Natick, Massachusetts, USA, Cognex has offices and
distributors located throughout the Americas, Europe and Asia. For
details visit Cognex online at www.cognex.com.
Certain statements made in this news release, which do not relate
solely to historical matters, are forward-looking statements. These
statements can be identified by use of the words "expects,"
"anticipates," "estimates," "believes," "projects," "intends," "plans,"
"will," "may," "shall," "could," "should," and similar words and other
statements of a similar sense. These forward-looking statements, which
include statements regarding business and market trends, future
financial performance, customer order rates and the timing of related
revenue, expected areas of growth, research and development activities,
further stock repurchases, investments, and strategic plans, involve
known and unknown risks and uncertainties that could cause actual
results to differ materially from those projected. Such risks and
uncertainties include: (1) the loss of a large customer; (2) current and
future conditions in the global economy; (3) the reliance on revenue
from the consumer electronics or automotive industries; (4) the
inability to penetrate new markets; (5) the inability to achieve
significant international revenue; (6) fluctuations in foreign currency
exchange rates and the use of derivative instruments; (7) information
security breaches or business system disruptions; (8) the inability to
attract and retain skilled employees; (9) the failure to effectively
manage our growth; (10) the reliance upon key suppliers to manufacture
and deliver critical components for our products; (11) the failure to
effectively manage product transitions or accurately forecast customer
demand; (12) the inability to design and manufacture high-quality
products; (13) the technological obsolescence of current products and
the inability to develop new products; (14) the failure to properly
manage the distribution of products and services; (15) the inability to
protect our proprietary technology and intellectual property; (16) our
involvement in time-consuming and costly litigation; (17) the impact of
competitive pressures; (18) the challenges in integrating and achieving
expected results from acquired businesses; (19) potential impairment
charges with respect to our investments or for acquired intangible
assets or goodwill; (20) exposure to additional tax liabilities; and
(21) the other risks detailed in Cognex reports filed with the SEC,
including its Form 10-K for the fiscal year ended December 31, 2017. You
should not place undue reliance upon any such forward-looking
statements, which speak only as of the date made. Cognex disclaims any
obligation to update forward-looking statements after the date of such
statements.
|
Exhibit 1
|
|
COGNEX CORPORATION Statements of Operations (Unaudited) Dollars
in thousands, except per share amounts
|
|
|
|
|
|
|
|
Three-months Ended
|
|
|
|
|
April 1,
2018
|
|
|
December 31, 2017 |
|
|
April 2,
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue (1)
|
|
|
$
|
169,567
|
|
|
|
$
|
182,922
|
|
|
|
$
|
139,039
|
|
|
Cost of revenue (1)
|
|
|
40,198
|
|
|
|
44,532
|
|
|
|
32,532
|
|
|
Gross margin
|
|
|
129,369
|
|
|
|
138,390
|
|
|
|
106,507
|
|
|
Percentage of revenue
|
|
|
76
|
%
|
|
|
76
|
%
|
|
|
77
|
%
|
|
Research, development, and engineering expenses (1)
|
|
|
31,076
|
|
|
|
26,980
|
|
|
|
22,770
|
|
|
Percentage of revenue
|
|
|
18
|
%
|
|
|
15
|
%
|
|
|
16
|
%
|
|
Selling, general, and administrative expenses (1)
|
|
|
63,697
|
|
|
|
60,635
|
|
|
|
46,521
|
|
|
Percentage of revenue
|
|
|
38
|
%
|
|
|
33
|
%
|
|
|
33
|
%
|
|
Operating income
|
|
|
34,596
|
|
|
|
50,775
|
|
|
|
37,216
|
|
|
Percentage of revenue
|
|
|
20
|
%
|
|
|
28
|
%
|
|
|
27
|
%
|
|
Foreign currency gain (loss)
|
|
|
(134
|
)
|
|
|
(1,027
|
)
|
|
|
(263
|
)
|
|
Investment and other income
|
|
|
3,517
|
|
|
|
2,923
|
|
|
|
2,282
|
|
|
Income before income tax expense
|
|
|
37,979
|
|
|
|
52,671
|
|
|
|
39,235
|
|
|
Income tax expense (benefit)
|
|
|
762
|
|
|
|
80,418
|
|
|
|
(6,236
|
)
|
|
Net income (loss)
|
|
|
$
|
37,217
|
|
|
|
$
|
(27,747
|
)
|
|
|
$
|
45,471
|
|
|
Percentage of revenue
|
|
|
22
|
%
|
|
|
(15
|
)%
|
|
|
33
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per weighted-average common and common-equivalent share (2):
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.21
|
|
|
|
$
|
(0.16
|
)
|
|
|
$
|
0.26
|
|
|
Diluted
|
|
|
$
|
0.21
|
|
|
|
$
|
(0.16
|
)
|
|
|
$
|
0.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common and common-equivalent shares outstanding (2):
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
173,280
|
|
|
|
173,397
|
|
|
|
172,646
|
|
|
Diluted
|
|
|
179,641
|
|
|
|
173,397
|
|
|
|
178,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per common share (2)
|
|
|
$
|
0.0450
|
|
|
|
$
|
0.0450
|
|
|
|
$
|
0.0375
|
|
|
Cash and investments per common share (2)
|
|
|
$
|
4.65
|
|
|
|
$
|
4.77
|
|
|
|
$
|
4.51
|
|
|
Book value per common share (2)
|
|
|
$
|
6.23
|
|
|
|
$
|
6.31
|
|
|
|
$
|
5.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Amounts include stock option expense, as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
$
|
797
|
|
|
|
$
|
477
|
|
|
|
$
|
430
|
|
|
Research, development, and engineering
|
|
|
4,815
|
|
|
|
2,932
|
|
|
|
2,610
|
|
|
Selling, general, and administrative
|
|
|
7,582
|
|
|
|
5,178
|
|
|
|
4,443
|
|
|
Total stock option expense
|
|
|
$
|
13,194
|
|
|
|
$
|
8,587
|
|
|
|
$
|
7,483
|
|
(2) Prior periods share and per share amounts have been adjusted to
reflect the 2-for-1 stock split of the Company's common stock that
occurred in the fourth quarter of 2017.
|
Exhibit 2
|
|
COGNEX CORPORATION Reconciliation of Selected Items
from GAAP to Non-GAAP (Unaudited) Dollars
in thousands, except per share amounts
|
|
|
|
|
|
|
|
|
|
Three-months Ended
|
|
|
|
|
April 1,
2018
|
|
|
December 31, 2017 |
|
|
April 2,
2017
|
|
Adjustment for stock option expense and tax benefit for stock
option exercises
|
|
|
|
|
|
Operating income (GAAP)
|
|
|
$
|
34,596
|
|
|
|
$
|
50,775
|
|
|
|
$
|
37,216
|
|
|
Stock option expense
|
|
|
13,194
|
|
|
|
8,587
|
|
|
|
7,483
|
|
|
Operating income (Non-GAAP)
|
|
|
$
|
47,790
|
|
|
|
$
|
59,362
|
|
|
|
$
|
44,699
|
|
|
Percentage of revenue (Non-GAAP)
|
|
|
28
|
%
|
|
|
32
|
%
|
|
|
32
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) (GAAP)
|
|
|
$
|
37,217
|
|
|
|
$
|
(27,747
|
)
|
|
|
$
|
45,471
|
|
|
Stock option expense
|
|
|
13,194
|
|
|
|
8,587
|
|
|
|
7,483
|
|
|
Tax effect on stock option expense
|
|
|
(2,347
|
)
|
|
|
(2,812
|
)
|
|
|
(2,439
|
)
|
|
Discrete tax benefit related to employee stock option exercises
|
|
|
(4,935
|
)
|
|
|
(10,995
|
)
|
|
|
(13,167
|
)
|
|
Net income (loss) (Non-GAAP)
|
|
|
$
|
43,129
|
|
|
|
$
|
(32,967
|
)
|
|
|
$
|
37,348
|
|
|
Percentage of revenue (Non-GAAP)
|
|
|
25
|
%
|
|
|
(18
|
%)
|
|
|
27
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per diluted weighted-average common and
common-equivalent share (GAAP) (1)
|
|
|
$
|
0.21
|
|
|
|
$
|
(0.16
|
)
|
|
|
$
|
0.25
|
|
|
Share impact of non-GAAP adjustments identified above (1)
|
|
|
0.03
|
|
|
|
(0.03
|
)
|
|
|
(0.04
|
)
|
|
Net income (loss) per diluted weighted-average common and
common-equivalent share
(Non-GAAP) (1)
|
|
|
$
|
0.24
|
|
|
|
$
|
(0.19
|
)
|
|
|
$
|
0.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted-average common and common-equivalent shares
outstanding (GAAP) (1)
|
|
|
179,641
|
|
|
|
173,397
|
|
|
|
178,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exclusion of tax adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income tax expense (GAAP)
|
|
|
$
|
37,979
|
|
|
|
$
|
52,671
|
|
|
|
$
|
39,235
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (GAAP)
|
|
|
$
|
762
|
|
|
|
$
|
80,418
|
|
|
|
$
|
(6,236
|
)
|
|
Effective tax rate (GAAP)
|
|
|
2
|
%
|
|
|
153
|
%
|
|
|
(16
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implications of the Tax Cuts and Jobs Act of 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transition tax on unrepatriated foreign earnings
|
|
|
$
|
—
|
|
|
|
$
|
101,379
|
|
|
|
$
|
—
|
|
|
Remeasurement of deferred tax positions
|
|
|
—
|
|
|
|
12,523
|
|
|
|
—
|
|
|
Recharacterization of certain income
|
|
|
—
|
|
|
|
(31,133
|
)
|
|
|
—
|
|
|
Subtotal
|
|
|
$
|
—
|
|
|
|
$
|
82,769
|
|
|
|
$
|
—
|
|
|
Discrete tax benefit related to employee stock option exercises
|
|
|
(4,935
|
)
|
|
|
(10,995
|
)
|
|
|
(13,167
|
)
|
|
Other discrete tax events
|
|
|
—
|
|
|
|
(594
|
)
|
|
|
(143
|
)
|
|
Income tax expense excluding tax adjustments (Non-GAAP)
|
|
|
$
|
5,697
|
|
|
|
$
|
9,238
|
|
|
|
$
|
7,074
|
|
|
Effective tax rate (Non-GAAP)
|
|
|
15%
|
|
|
|
18
|
%
|
|
|
18
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income excluding tax adjustments (Non-GAAP)
|
|
|
$
|
32,282
|
|
|
|
$
|
43,433
|
|
|
|
$
|
32,161
|
|
|
Percentage of revenue (Non-GAAP)
|
|
|
19%
|
|
|
|
24
|
%
|
|
|
23
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per diluted weighted-average common and
common-equivalent share (GAAP) (1)
|
|
|
$
|
0.21
|
|
|
|
$
|
(0.16
|
)
|
|
|
$
|
0.25
|
|
|
Share impact of non-GAAP adjustments identified above (1)
|
|
|
(0.03
|
)
|
|
|
0.40
|
|
|
|
(0.07
|
)
|
|
Net income per diluted weighted-average common and common-equivalent
share (Non-GAAP) (1)
|
|
|
$
|
0.18
|
|
|
|
$
|
0.24
|
|
|
|
$
|
0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted-average common and common-equivalent shares
outstanding (GAAP) (1) (2)
|
|
|
179,641
|
|
|
|
180,542
|
|
|
|
178,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Prior periods share and per share amounts have been adjusted to
reflect the 2-for-1 stock split of the Company's common stock that
occurred in the fourth quarter of 2017
(2) For the fourth quarter of 2017, includes potential common stock
equivalents of 7,145 that were excluded in the GAAP net loss per share
calculation because they were anti-dilutive.
|
Exhibit 3
|
|
COGNEX CORPORATION
|
|
Balance Sheets
|
|
(Unaudited)
|
|
Dollars in thousands
|
|
|
|
|
|
|
April 1, 2018
|
|
|
December 31, 2017 |
|
Assets
|
|
|
|
|
|
|
|
Cash and investments
|
|
|
$
|
803,382
|
|
|
|
$
|
827,984
|
|
Accounts receivable
|
|
|
96,649
|
|
|
|
119,388
|
|
Unbilled revenue
|
|
|
4,232
|
|
|
|
7,454
|
|
Inventories
|
|
|
96,399
|
|
|
|
67,923
|
|
Property, plant, and equipment
|
|
|
85,205
|
|
|
|
78,048
|
|
Goodwill and intangible assets
|
|
|
125,628
|
|
|
|
126,397
|
|
Other assets
|
|
|
57,420
|
|
|
|
60,559
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
$
|
1,268,915
|
|
|
|
$
|
1,287,753
|
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
|
$
|
85,599
|
|
|
|
$
|
91,712
|
|
Deferred revenue and customer deposits
|
|
|
15,504
|
|
|
|
9,420
|
|
Income taxes
|
|
|
85,933
|
|
|
|
85,044
|
|
Other liabilities
|
|
|
4,780
|
|
|
|
5,904
|
|
Shareholders' equity
|
|
|
1,077,099
|
|
|
|
1,095,673
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
|
$
|
1,268,915
|
|
|
|
$
|
1,287,753
|
|
Exhibit 4
|
COGNEX CORPORATION Restated Statements of Operations
under ASC 606 "Revenue from Contracts with Customers" (Unaudited) Dollars
in thousands
|
|
|
|
|
|
|
|
Three-months Ended
|
|
|
|
|
April 2,
2017
|
|
|
July 2,
2017
|
|
|
October 1, 2017 |
|
|
December 31, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
$
|
139,039
|
|
|
|
$
|
178,080
|
|
|
|
$
|
266,042
|
|
|
|
$
|
182,922
|
|
|
Cost of revenue
|
|
|
32,532
|
|
|
|
42,164
|
|
|
|
68,061
|
|
|
|
44,532
|
|
|
Gross margin
|
|
|
106,507
|
|
|
|
135,916
|
|
|
|
197,981
|
|
|
|
138,390
|
|
|
Percentage of revenue
|
|
|
77
|
%
|
|
|
76
|
%
|
|
|
74
|
%
|
|
|
76
|
%
|
|
Research, development, and engineering expenses
|
|
|
22,770
|
|
|
|
23,377
|
|
|
|
26,078
|
|
|
|
26,980
|
|
|
Percentage of revenue
|
|
|
16
|
%
|
|
|
13
|
%
|
|
|
10
|
%
|
|
|
15
|
%
|
|
Selling, general, and administrative expenses
|
|
|
46,521
|
|
|
|
52,518
|
|
|
|
61,054
|
|
|
|
60,635
|
|
|
Percentage of revenue
|
|
|
33
|
%
|
|
|
29
|
%
|
|
|
23
|
%
|
|
|
33
|
%
|
|
Operating income
|
|
|
37,216
|
|
|
|
60,021
|
|
|
|
110,849
|
|
|
|
50,775
|
|
|
Percentage of revenue
|
|
|
27
|
%
|
|
|
34
|
%
|
|
|
42
|
%
|
|
|
28%
|
|
|
Foreign currency gain (loss)
|
|
|
(263
|
)
|
|
|
(184
|
)
|
|
|
(127
|
)
|
|
|
(1,027
|
)
|
|
Investment and other income
|
|
|
2,282
|
|
|
|
1,969
|
|
|
|
2,030
|
|
|
|
2,923
|
|
|
Income before income tax expense
|
|
|
39,235
|
|
|
|
61,806
|
|
|
|
112,752
|
|
|
|
52,671
|
|
|
Income tax expense (benefit)
|
|
|
(6,236
|
)
|
|
|
5,311
|
|
|
|
10,259
|
|
|
|
80,418
|
|
|
Net income (loss)
|
|
|
$
|
45,471
|
|
|
|
$
|
56,495
|
|
|
|
$
|
102,493
|
|
|
|
$
|
(27,747
|
)
|
|
Percentage of revenue
|
|
|
33
|
%
|
|
|
32
|
%
|
|
|
39
|
%
|
|
|
(15
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per weighted-average common and common-equivalent share (1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.26
|
|
|
|
$
|
0.33
|
|
|
|
$
|
0.59
|
|
|
|
$
|
(0.16
|
)
|
|
Diluted
|
|
|
$
|
0.25
|
|
|
|
$
|
0.32
|
|
|
|
$
|
0.57
|
|
|
|
$
|
(0.16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common and common-equivalent shares outstanding (1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
172,646
|
|
|
|
173,278
|
|
|
|
173,234
|
|
|
|
173,397
|
|
|
Diluted
|
|
|
178,354
|
|
|
|
179,228
|
|
|
|
179,354
|
|
|
|
173,397
|
|
(1) Prior periods share and per share amounts have been adjusted to
reflect the 2-for-1 stock split of the Company's common stock that
occurred in the fourth quarter of 2017.
Adjustments to certain financial data as a result of the
implementation of ASC 606 "Revenue from Contracts with Customers on
Jan.1 2018"
|
|
|
|
Three-months Ended
|
|
|
|
|
April 2,
2017
|
|
|
July 2,
2017
|
|
|
October 1,
2017
|
|
|
December 31,
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue as reported
|
|
|
$
|
134,942
|
|
|
|
$
|
172,904
|
|
|
|
$
|
259,739
|
|
|
|
$
|
180,365
|
|
|
Adjustments to revenue
|
|
|
4,097
|
|
|
|
5,176
|
|
|
|
6,303
|
|
|
|
2,557
|
|
|
Revenue as restated
|
|
|
$
|
139,039
|
|
|
|
$
|
178,080
|
|
|
|
$
|
266,042
|
|
|
|
$
|
182,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue as reported
|
|
|
28,225
|
|
|
|
37,471
|
|
|
|
62,360
|
|
|
|
40,642
|
|
|
Adjustments to cost of revenue
|
|
|
4,307
|
|
|
|
4,693
|
|
|
|
5,701
|
|
|
|
3,890
|
|
|
Cost of revenue as restated
|
|
|
$
|
32,532
|
|
|
|
$
|
42,164
|
|
|
|
$
|
68,061
|
|
|
|
$
|
44,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin as reported
|
|
|
$
|
106,717
|
|
|
|
$
|
135,433
|
|
|
|
$
|
197,379
|
|
|
|
$
|
139,723
|
|
|
Adjustments to gross margin
|
|
|
(210
|
)
|
|
|
483
|
|
|
|
602
|
|
|
|
(1,333
|
)
|
|
Gross margin as restated
|
|
|
$
|
106,507
|
|
|
|
135,916
|
|
|
|
$
|
197,981
|
|
|
|
$
|
138,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin percentage as reported
|
|
|
79%
|
|
|
78%
|
|
|
76%
|
|
|
77%
|
|
Adjustments to gross margin percentage
|
|
|
(2)%
|
|
|
(2)%
|
|
|
(2)%
|
|
|
(1)%
|
|
Gross margin percentage as restated
|
|
|
77%
|
|
|
76%
|
|
|
74%
|
|
|
76%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income as reported
|
|
|
$
|
37,426
|
|
|
|
$
|
59,538
|
|
|
|
$
|
110,247
|
|
|
|
$
|
52,108
|
|
|
Adjustments to operating income
|
|
|
(210
|
)
|
|
|
483
|
|
|
|
602
|
|
|
|
(1,333
|
)
|
|
Operating income as restated
|
|
|
$
|
37,216
|
|
|
|
$
|
60,021
|
|
|
|
$
|
110,849
|
|
|
|
$
|
50,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin as reported
|
|
|
28%
|
|
|
34%
|
|
|
42%
|
|
|
29%
|
|
Adjustments to operating margin
|
|
|
(1)%
|
|
|
—%
|
|
|
—%
|
|
|
(1)%
|
|
Operating margin as restated
|
|
|
27%
|
|
|
34%
|
|
|
42%
|
|
|
28%
|

View source version on businesswire.com: https://www.businesswire.com/news/home/20180430006375/en/
Cognex Corporation
Susan Conway, 508-650-3353
Senior Director
of Investor Relations
susan.conway@cognex.com
Source: Cognex Corporation
News Provided by Acquire Media